A pilot randomized controlled trial of 7 versus 14 days of antibiotic treatment for bloodstream infection on non-intensive care versus intensive care wards

A pilot randomized controlled trial of 7 versus 14 days of antibiotic treatment for bloodstream infection on non-intensive care versus intensive care wards

Abstract Background The optimal treatment duration for patients with bloodstream infection is understudied. The Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) pilot randomized clinical trial (RCT) determined that it was feasible to enroll and randomize intensive ca...

Full description

Bibliographic Details
Main Authors: Nick Daneman, Asgar H. Rishu, Ruxandra Pinto, Yaseen Arabi, Emilie P. Belley-Cote, Robert Cirone, Mark Downing, Deborah J. Cook, Richard Hall, Shay McGuinness, Lauralyn McIntyre, John Muscedere, Rachael Parke, Steven Reynolds, Benjamin A. Rogers, Yahya Shehabi, Phillip Shin, Richard Whitlock, Robert A. Fowler, on behalf of the Canadian Critical Care Trials Group
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Trials
Subjects:
Bacteremia
Bloodstream infection
Critical care
Intensive care
Duration of treatment
Online Access:https://doi.org/10.1186/s13063-019-4033-9

Internet

https://doi.org/10.1186/s13063-019-4033-9

Similar Items